Product Information
VIMPAT 50 MG TABLET is a brand product labeled by UCB, Inc., priced at $11.8216 per EA under NDC 00131247735. Its NADAC has been published 657 times since Nov 28, 2013.
The High Outlier badge above means this manufacturer's average price in the lacosamide market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
50 mg/1
Manufacturer
UCB, Inc.NDC
00131247735
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
LACOSAMIDEApproval Type
New Drug (NDA)
FDA Application
NDA022253On Market Since
5/26/2009
Pharmacological Classes
Price Statistics
The NADAC for VIMPAT 50 MG TABLET has been published 657 times since Nov 28, 2013, and over the history we have for it it has risen 115.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $11.8216 per EA |
|---|---|
| All-time high | $11.8546 (May 13, 2026) |
| All-time low | $5.4781 (Nov 28, 2013) |
| 52-week high | $11.8546 |
| 52-week low | $11.5467 |
| Median price | $9.0924 |
| Average price | $8.9864 |
| Largest weekly change | +9.9% (Jan 8, 2014) |
| Weeks tracked | 657 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 99% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of VIMPAT 50 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for VIMPAT 50 MG TABLET, manufactured by UCB, Inc., is $11.8216 per EA (NDC 00131247735), effective Jun 24, 2026.
How has the price of VIMPAT 50 MG TABLET changed over time?
Over the history we have for it, the NADAC for VIMPAT 50 MG TABLET has risen 115.8%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for VIMPAT 50 MG TABLET?
Since Nov 28, 2013, the NADAC for VIMPAT 50 MG TABLET has ranged from a low of $5.4781 (Nov 28, 2013) to a high of $11.8546 (May 13, 2026), with a median of $9.0924 per EA.
Are there cheaper alternatives to VIMPAT 50 MG TABLET?
Yes. 3 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, LACOSAMIDE 50 MG TABLET, is $0.1108 per EA — about 99% below VIMPAT 50 MG TABLET.
Who manufactures VIMPAT 50 MG TABLET?
VIMPAT 50 MG TABLET (NDC 00131247735) is labeled by UCB, Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification